Business Access Manager, Biosimilars, Northern UK at IQVIA

Manchester, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, BiosimilarsIndustries

Requirements

Bachelor’s or Master’s degree in Business, Health Economics, Life Sciences, or a related field
ABPI qualified
Strong experience in nephrology, particularly in rare diseases such as PNH, aHUS, or with complement inhibitors
Prior experience in biosimilars or biologics highly desirable
3–5 years in UK pharmaceutical sales, engaging with specialist stakeholders in secondary care
Proven ability to develop impactful partnerships with internal and external stakeholders
Resilient team player with strong leadership and communication skills
Creative thinker with excellent presentation and influencing capabilities
Willing to travel regularly across the UK; proximity to major transport links (motorways, rail, airports) advantageous
Full UK driving licence required
Located in the North of England (Manchester, Leeds, Newcastle, or surrounding areas preferred)

Responsibilities

Manage commercial activities across 30–40 specialist rare disease centres throughout the UK
Build strong relationships with hospital stakeholders including clinicians, hospital managers, and high-cost drug pharmacists to drive product uptake and patient access
Partner with internal teams to ensure decision-makers are fully informed and supported for optimal prescribing
Position the company as a trusted partner in the biosimilars and biologics space
Monitor and report on competitor activity, treatment trends, and prescribing criteria
Achieve sales targets and contribute to market share growth

Skills

ABPI

Nephrology

PNH

aHUS

Complement Inhibitors

Biosimilars

Biologics

Stakeholder Engagement

Pharma Sales

Market Access

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free